Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | GPR3 | P46089 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | KIF11 | P52732 | 11/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TNKS | O95271 | 1/20 | 0.44 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31850 | 1.00 | AHR (0.61) | AHRALDH1A1GPR3HSD17B10MAPT | |
| SCHEMBL29506383 | 1.00 | AHR (0.61) | AHRALDH1A1GPR3HSD17B10MAPT | |
| SCHEMBL16999821 | 0.96 | AHR (0.65) | AHRALDH1A1GPR3HSD17B10MAPT | |
| SCHEMBL10014622 | 0.93 | AHR (0.67) | AHRALDH1A1GPR3HSD17B10MAPT | |
| SCHEMBL29470198 | 0.93 | AHR (0.67) | AHRALDH1A1GPR3HSD17B10MAPT | |
| SCHEMBL17071059 | 0.91 | AHR (0.60) | AHRALDH1A1GPR3HSD17B10MAPT | |
| Carbazole SCHEMBL22577587 | 0.88 | ALDH1A1 (0.67) | AHRALDH1A1GPR3HSD17B10MAPT | |
| Carbazole SCHEMBL29283446 | 0.88 | ALDH1A1 (0.67) | AHRALDH1A1GPR3HSD17B10MAPT | |
| SCHEMBL19636067 | 0.88 | AHR (0.55) | AHRALDH1A1GPR3HSD17B10MAPT | |
| SCHEMBL19636273 | 0.86 | GPR3 (0.48) | AHRALDH1A1GPR3HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260026260-A1 | LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-01-22 | — | — | US | claimed |
| US-20260026260-A1 | LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-01-22 | — | — | US | disclosed |
| CN-114163441-B | Organic compound, organic light emitting diode comprising the same, and organic light emitting device | 乐金显示有限公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-114195768-B | Organic compound and organic electroluminescent device | 北京燕化集联光电技术有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-111886236-B | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-06-20 | — | — | CN | disclosed |
| CN-116253753-A | Luminescent material, application thereof and organic electroluminescent device comprising luminescent material | 清华大学 | 2023-06-13 | — | — | CN | disclosed |
| WO-2022250228-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | 엘티소재주식회사 | 2022-12-01 | — | — | WO | disclosed |
| CN-114163441-A | Organic compound, organic light emitting diode including the same, and organic light emitting device | 乐金显示有限公司 | 2022-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026260-A1 | LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND | CRY1, SCO2, CYBA | AHR 416/4885ALDH1A1 302/4885GPR3 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.